on INVENTIVA (EPA:IVA)
Inventiva to present at the JP Morgan Healthcare Conference
Inventiva, a French-American biopharmaceutical company, will participate in the 43rd annual JP Morgan Healthcare Conference. This event will take place from January 13 to 16, 2025 in San Francisco. Frédéric Cren, CEO and co-founder, will present the company's activities. Inventiva specializes in the clinical development of small molecules to treat nonalcoholic steatohepatitis (NASH) and other diseases.
The program includes a presentation of Inventiva’s lead medical candidate, lanifibranor, currently in Phase III of the NATiV3 study. Cren and his team will also meet with investors to discuss the company’s progress and strategies. Investors can follow the event via a live streaming link or replay.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INVENTIVA news